Morningstar Fund Report

Aberdeen Japan Growth A
Performance History31/10/2009
Growth of 1,000 (GBP)Advanced Graph
Performance History
Fund25.5-9.8-14.4-5.1-2.7
+/-Cat-16.01.4-5.22.43.6
+/-Idx-14.9-3.0-8.6-3.14.4
 
 
 
Trailing Returns 20/11/2009
 Fund +/-Idx
YTD-5.73 5.53
3 Years Annualised-6.75 -2.11
5 Years Annualised-2.38 -3.96
10 Years Annualised-6.01 -2.44
 
 
12 Month Yield 0.50
Tax Year Return -8.68%
 
Key Stats
Japan Large-Cap Equity
IMA Sector
Japan
ISIN
GB0004521620
NAV   20/11/2009
British Pence 88.72
Day Change
0.76%
Total Expense Ratio
1.57%
Manager Name
--- Management Team
Inception Date
01/08/1992
ISA
Yes
 
Benchmarks
 
Fund Benchmark 
Topix
Morningstar Benchmark 
MSCI Japan NR USD
 
 
 
 
Investment Objective
 
The fund aims to produce capital growth through investment in a diversified portfolio of Japanese securities.
 
Portfolio Profile  31/10/2009
Morningstar Style Box® 
Equity Style
 
 
Asset Allocation %  
Stock98.40
Bonds0.00
Property0.00
Cash1.60
Other0.00
 
 
Top 5 Regions%
Japan100.00
United States0.00
Canada0.00
Latin America0.00
United Kingdom0.00
 
 
Top 5 Sectors%
Consumer Goods44.94
Industrial Materials19.79
Financial Services15.88
Healthcare10.68
Consumer Services7.19
 
 
Top 5 HoldingsSector%
Takeda Pharmaceutical Co., Ltd.HealthcareHealthcare5.26
Astellas Pharma Inc.HealthcareHealthcare5.24
Canon, Inc.Consumer GoodsConsumer Goods5.15
Mitsubishi EstateFinancial ServicesFinancial Services4.78
Shin-Etsu Chemical Co., Ltd.Industrial MaterialsIndustrial Materials4.55
 
 
Fund Facts
Sales Charges
Initial Charge4.25%
Our Discount4.25%
ISC You Pay0.00%
 
 
Care is taken to ensure that the information provided by Morningstar is correct but neither we nor Morningstar warrant, represent or guarantee the contents of the information, nor do we or Morningstar accept any responsibility for errors, inaccuracies, omissions or any inconsistencies herein. The information should not be regarded as specific investment advice or a personal recommendation of any kind.

© Copyright 2009 Morningstar. All rights reserved. Please read our Terms of Use.